Saturday 17 October 2026
Export GCTK’s income statement to Excel — free account
GlucoTrack, Inc.
GCTK Healthcare Medical Instruments & Supplies
In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.
0.73
0.10
−12.05%
Follow GCTK
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 3 | 1 | 2 | 2 |
P/E ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | — | — | 26,019,048.63 | 827,344.05 | 483,614.12 | 757,570.46 |
P/S ratio |
— | — | — | — | — | — | 522,885,375.00 | 9,303,494.32 | 24,952,324.40 | 27,686,110.20 |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | (301.18) | (505.41) | (145.73) | (64.35) |
P/Operating CF |
— | — | — | — | — | — | (136,547,593.22) | (4,507,473.85) | (18,663,578.68) | (17,537,881.93) |
Beneish M-Score |
— | — | — | — | — | — | 2.40 | (14.97) | (15.03) | 0.36 |
P/B ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | — | — | 522,885,374.04 | 9,303,494.51 | 24,952,324.66 | 27,686,110.27 |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | (27,894,372.35) | (1,004,076.83) | (2,494,809.19) | (3,187,775.34) |
EV/FCF |
— | — | — | — | — | — | (27,730,789.85) | (1,002,969.78) | (2,486,583.85) | (3,142,517.13) |
Quick Ratio |
1.55 | 4.41 | 2.97 | 2.28 | 6.87 | 7.35 | 0.22 | 0.04 | 0.05 | 0.10 |
Current Ratio |
1.61 | 4.52 | 3.22 | 2.35 | 6.91 | 7.61 | 0.32 | 0.10 | 0.33 | 0.86 |
Net Debt/EBITDA |
0.25 | 0.37 | 0.61 | 0.48 | 1.46 | 3.09 | 0.02 | (0.01) | (0.01) | 0.00 |
Debt/Assets |
43.54% | 3.51% | 4.00% | 8.00% | 3.72% | 2.65% | 30.38% | 24.44% | 10.95% | 6.58% |
Debt/Equity |
1.21 | (0.02) | 0.06 | 0.16 | 0.05 | 0.03 | (0.24) | (0.06) | (0.01) | (0.01) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.04 | 0.29 | 0.27 |
Operating CF/Net income |
0.79 | 0.55 | 0.92 | 0.84 | 0.93 | 1.30 | 1.11 | 0.73 | 0.57 | 0.98 |
Capex/Depreciation |
(0.43) | (2.89) | 0.00 | 0.04 | (0.02) | (1.13) | (0.45) | (0.09) | (0.29) | (1.28) |
| 381.20% | 461.02% | (320.62%) | (138.92%) | (57.54%) | (71.23%) | 164.10% | 69.06% | 75.05% | 60.38% | |
| (281.60%) | (417.03%) | (193.30%) | (101.92%) | (48.21%) | (46.08%) | (394.13%) | (569.80%) | (500.21%) | (235.53%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(639.45%) | (492.52%) | (209.78%) | (315.43%) | (76.87%) | (29.85%) | 247.61% | 243.51% | 460.68% | 5,997.45% |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 122.84 | 191.31 | 75.41 | 54.96 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 772.12% | 6,972.18% | 544.11% | 471.11% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,013.46% | 8,159.08% | 1,349.92% | 553.49% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 171.15% | 1,621.15% | 458.90% | 11.48% |
Graham Net Nets |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
— | — | — | — | — | — | 0.07 | 2.48 | 9.88 | 6.31 |
Earnings Yield |
— | — | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow Yield |
— | — | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 | 0.11 |
Operating CF per Share |
(368.12) | (31,225.00) | (32,790.00) | (18,645.00) | (18,845.00) | (17,505.00) | (0.03) | (0.58) | (0.94) | (0.92) |
Capex per Share |
(2.32) | (260.00) | 0.00 | 5.00 | (5.00) | (265.00) | 0.00 | 0.00 | 0.00 | (0.01) |
Free Cash Flow per Share |
(370.43) | (31,485.00) | (32,790.00) | (18,640.00) | (18,850.00) | (17,770.00) | (0.03) | (0.58) | (0.94) | (0.93) |
Cash per Share |
178.33 | 14,042.50 | 22,460.00 | 11,560.00 | 30,310.00 | 49,115.00 | 0.00 | 0.01 | 0.01 | 0.03 |
Shareholders Equity per Share |
68.31 | (32,500.00) | 15,985.00 | 6,150.00 | 25,775.00 | 44,910.00 | (0.01) | (0.34) | (2.64) | (1.89) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
68.31 | (32,500.00) | 15,985.00 | 6,150.00 | 25,775.00 | 44,910.00 | (0.01) | (0.34) | (2.64) | (1.89) |
Free Cash Flow |
(15.34) | (12.59) | (6.56) | (3.73) | (3.77) | (3.55) | (3.92) | (4.90) | (5.91) | (5.39) |
Working Capital |
2.89 | 4.49 | 3.36 | 1.37 | 5.22 | 8.88 | (1.55) | (2.91) | (2.46) | (0.33) |
Capital Expenditures |
(0.10) | (0.10) | — | 0.00 | 0.00 | (0.05) | (0.02) | (0.01) | (0.02) | (0.08) |
Net Current Asset Value |
2.66 | (13.16) | 3.16 | 1.17 | 5.00 | 8.61 | (1.79) | (3.25) | (17.02) | (11.39) |
EV/EBIT |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.11 | 0.12 | 0.03 | 0.13 |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.62 | 0.38 | 0.48 | 0.58 | 0.61 | 0.32 | 0.38 | 0.39 | 0.31 | 0.25 |
Cash ROIC |
(112.57%) | 175.53% | (83.17%) | (99.76%) | (32.93%) | (18.62%) | 594.24% | 187.80% | 36.20% | 50.65% |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 4.48 | 0.60 | 5.51 | 11.07 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | 0.07 | 0.05 | 0.07 | 0.11 | 0.06 |
Average Payables |
1.15 | 0.92 | 0.76 | 0.65 | 0.75 | 1.20 | 1.80 | 2.24 | 2.03 | 1.36 |
Average Inventory |
— | — | — | — | 0.14 | 0.23 | 0.18 | 0.56 | 1.19 | 1.12 |
Average Assets |
6.89 | 5.42 | 3.67 | 4.35 | 8.44 | 5.85 | 0.89 | 1.18 | 2.06 | 2.30 |
Average Common Equity |
(5.09) | (4.90) | 2.21 | 3.19 | 7.07 | 3.79 | (2.14) | (9.72) | (13.76) | (8.96) |
Columns are period end dates